Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release

PA van Setten, LA Monnens, RG Verstraten, LP van den Heuvel, VW van Hinsbergh

Blood (1996) 88 (1): 174–183.

https://doi.org/10.1182/blood.V88.1.174.174

Published: 1996

Journal Articles

Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C

NC van de Kar, T Kooistra, M Vermeer, W Lesslauer, LA Monnens, VW van Hinsbergh

Blood (1995) 85 (3): 734–743.

https://doi.org/10.1182/blood.V85.3.734.bloodjournal853734

Published: 1995

Journal Articles

Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells

VW van Hinsbergh, M Vermeer, P Koolwijk, J Grimbergen, T Kooistra

Blood (1994) 84 (9): 2984–2991.

https://doi.org/10.1182/blood.V84.9.2984.2984

Published: 1994

Journal Articles

Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome

NC van de Kar, LA Monnens, MA Karmali, VW van Hinsbergh

Blood (1992) 80 (11): 2755–2764.

https://doi.org/10.1182/blood.V80.11.2755.2755

Published: 1992

Journal Articles

Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products

VW van Hinsbergh, KA Bauer, T Kooistra, C Kluft, G Dooijewaard, ML Sherman, W Nieuwenhuizen

Blood (1990) 76 (11): 2284–2289.

https://doi.org/10.1182/blood.V76.11.2284.2284

Published: 1990

Journal Articles

Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells

VW van Hinsbergh, EA van den Berg, W Fiers, G Dooijewaard

Blood (1990) 75 (10): 1991–1998.

https://doi.org/10.1182/blood.V75.10.1991.1991

Published: 1990

Journal Articles

Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells

VW van Hinsbergh, T Kooistra, MA Scheffer, J Hajo van Bockel, GN van Muijen

Blood (1990) 75 (7): 1490–1497.

https://doi.org/10.1182/blood.V75.7.1490.1490

Published: 1990

Journal Articles

Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo

VW van Hinsbergh, T Kooistra, EA van den Berg, HM Princen, W Fiers, JJ Emeis

Blood (1988) 72 (5): 1467–1473.

https://doi.org/10.1182/blood.V72.5.1467.1467

Published: 1988

Journal Articles

The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro

NJ de Fouw, F Haverkate, RM Bertina, J Koopman, A van Wijngaarden, VW van Hinsbergh

Blood (1986) 67 (4): 1189–1192.

https://doi.org/10.1182/blood.V67.4.1189.1189

Published: 1986

Journal Articles

The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood

C Kluft, P Los, AF Jie, VW van Hinsbergh, E Vellenga, J Jespersen, CP Henny

Blood (1986) 67 (3): 616–622.

https://doi.org/10.1182/blood.V67.3.616.616

Published: 1986

Journal Articles

Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium

VW van Hinsbergh, RM Bertina, A van Wijngaarden, NH van Tilburg, JJ Emeis, F Haverkate

Blood (1985) 65 (2): 444–451.

https://doi.org/10.1182/blood.V65.2.444.444

Published: 1985

NARROW

Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release

Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C

Genistein reduces tumor necrosis factor alpha-induced plasminogen activator inhibitor-1 transcription but not urokinase expression in human endothelial cells

Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome

Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products

Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells

Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells

Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo

The cofactor role of protein S in the acceleration of whole blood clot lysis by activated protein C in vitro

The mutual relationship between the two molecular forms of the major fibrinolysis inhibitor alpha-2-antiplasmin in blood

Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only